We are live on
!
Find out more
PC
PointState Capital Portfolio holdings
AUM
$7.9B
1-Year Est. Return
42.31%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.79B
AUM Growth
+$734M
(+15%)
Cap. Flow
+$336M
Cap. Flow
% of AUM
5.8%
Top 10 Holdings %
Top 10 Hldgs %
38.36%
Holding
177
New
61
Increased
32
Reduced
27
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$153M |
| 2 |
WIX.com
WIX
|
+$144M |
| 3 |
Netflix
NFLX
|
+$115M |
| 4 |
Exelon
EXC
|
+$114M |
| 5 |
Palo Alto Networks
PANW
|
+$87.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$152M |
| 2 |
Devon Energy
DVN
|
+$130M |
| 3 |
UnitedHealth
UNH
|
+$127M |
| 4 |
Intuit
INTU
|
+$116M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.19% |
| 2 | Consumer Discretionary | 8.42% |
| 3 | Healthcare | 7.45% |
| 4 | Communication Services | 6.92% |
| 5 | Financials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$124B
| $10.1M | 0.17% |
50,000
| – | – |
|
77
ASML
ASML
$619B
| $9.81M | 0.17% |
14,207
-10,686
| -43% | -$7.05M |
|
78
Elanco Animal Health
ELAN
$13B
| $9.72M | 0.17% |
280,300
-11,200
| -4% | -$369K |
|
79
Merck
MRK
$323B
| $9.33M | 0.16% |
120,000
+83,320
| +227% | +$6.2M |
|
80
CALL
Gilead Sciences
GILD
$167B
| $8.61M | 0.15% |
125,000
+50,000
| +67% | +$3.34M |
|
|
SGEN
81
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.21M | 0.14% |
+52,000
| New | +$7.73M |
|
82
CVS Health
CVS
$137B
| $7.93M | 0.14% |
95,000
-132,200
| -58% | -$10.8M |
|
83
CALL
Pfizer
PFE
$143B
| $7.83M | 0.14% |
200,000
-100,000
| -33% | -$3.89M |
|
84
Intuitive Surgical
ISRG
$127B
| $7.36M | 0.13% |
+24,000
| New | +$6.73M |
|
85
Edwards Lifesciences
EW
$49.4B
| $7.25M | 0.13% |
+70,000
| New | +$6.6M |
|
86
GSK
GSK
$106B
| $6.81M | 0.12% |
+136,800
| New | +$6.57M |
|
87
Bio-Rad Laboratories Class A
BIO
$8.74B
| $6.44M | 0.11% |
+10,000
| New | +$6.09M |
|
88
AvalonBay Communities
AVB
$27.6B
| $6.25M | 0.11% |
29,970
-9,700
| -24% | -$1.94M |
|
89
Equity Residential
EQR
$25.8B
| $6.12M | 0.11% |
79,428
-25,610
| -24% | -$1.94M |
|
90
Medtronic
MDT
$112B
| $5.83M | 0.1% |
47,000
-67,700
| -59% | -$8.5M |
|
|
OSH
91
DELISTED
Oak Street Health, Inc.
OSH
| $5.27M | 0.09% |
90,000
+24,182
| +37% | +$1.44M |
|
92
Mercado Libre
MELI
$96.1B
| $5.21M | 0.09% |
3,342
-18,752
| -85% | -$27.5M |
|
|
HZNP
93
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.15M | 0.09% |
+55,000
| New | +$5.06M |
|
94
Intel
INTC
$438B
| $5.05M | 0.09% |
90,000
-636,542
| -88% | -$37.4M |
|
95
Thermo Fisher Scientific
TMO
$214B
| $5.04M | 0.09% |
10,000
-1,000
| -9% | -$472K |
|
96
Tenet Healthcare
THC
$22.4B
| $5.02M | 0.09% |
+75,000
| New | +$4.65M |
|
97
Teladoc Health
TDOC
$1.68B
| $4.99M | 0.09% |
30,000
+15,000
| +100% | +$2.43M |
|
98
Privia Health
PRVA
$3.06B
| $4.88M | 0.08% |
+110,000
| New | +$4.06M |
|
99
IQVIA
IQV
$40.5B
| $4.85M | 0.08% |
+20,000
| New | +$4.62M |
|
100
Labcorp
LH
$25.4B
| $4.14M | 0.07% |
+17,460
| New | +$3.98M |
|
Similar funds
CIP
IMRF
SF
CMTU
PGFC
EGM
PA
MT
PointState Capital's Q2 2021 Portfolio in Review
As of Q2 2021, PointState Capital held 177 positions worth $5.79B, up 15% from $5.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
PointState Capital deployed $336M of net new capital in Q2 2021, opening 61 new positions and adding to 32 existing holdings. Its largest new stake was Allstate: 1,184,898 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was UnitedHealth, an estimated $127M trimmed.
- PointState Capital's largest Q2 2021 buy was Allstate: 1,184,898 shares worth $155M.
- PointState Capital added most to Netflix in Q2 2021, an estimated $115M increase.
- PointState Capital's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $127M.
- PointState Capital fully exited Alphabet (Google) Class A in Q2 2021, selling an estimated $152M.
- PointState Capital's ten largest holdings make up 38% of its $5.79B portfolio in Q2 2021.
- PointState Capital opened 61 new positions and closed 51 in Q2 2021.
- PointState Capital's portfolio value rose 15% quarter-over-quarter to $5.79B.
Based on PointState Capital's 13F filing for Q2 2021, filed 13 Aug 2021.